Table 2.
I. Metric | II. Experimental groups | III. Condition | IV. Compiled number of nuclei | V. Number of coverslips | VI. Test and sample size used |
---|---|---|---|---|---|
Density | Control A1 | Static | 2513 | 14 | ANOVA coverslips (column V) |
Stretch | 2390 | 18 | |||
Control A1 (72-h) | Static | 2602 | 16 | ||
Stretch | 1713 | 13 | |||
Patient A1 | Static | 2108 | 12 | ||
Stretch | 2922 | 18 | |||
Patient A1 | Static | 2293 | 13 | ||
(72-h) | Stretch | 1839 | 15 | ||
Actin OOP | Control A1 | Static | N/A | 14 | ANOVA coverslips (column V) |
Stretch | 18 | ||||
Control A1 (72-h) | Static | N/A | 16 | ||
Stretch | 13 | ||||
Patient A1 | Static | N/A | 12 | ||
Stretch | 18 | ||||
Patient A1 | Static | N/A | 13 | ||
(72-h) | Stretch | 15 | |||
Fibronectin OOP | Control A1 | Static | N/A | 6 | ANOVA coverslips (column V) |
Stretch | 10 | ||||
Control A1 (72-h) | Static | N/A | 16 | ||
Stretch | 13 | ||||
Patient A1 | Static | N/A | 6 | ||
Stretch | 12 | ||||
Patient A1 | Static | N/A | 13 | ||
(72-h) | Stretch | 15 | |||
% Defective nuclei | Control A1 | Static | 267 | 14 | Kruskal–Wallis and Dunn's multiple comparison coverslips (column V) |
Stretch | 358 | 18 | |||
Control A1 (72-h) | Static | 1554 | 16 | ||
Stretch | 1080 | 13 | |||
Patient A1 | Static | 292 | 12 | ||
Stretch | 519 | 18 | |||
Patient A1 | Static | 1368 | 13 | ||
(72-h) | Stretch | 1223 | 15 | ||
Aspect ratio and area | Control A1 | Static | 267 | 14 | ANOVA nuclei (column IV) |
Stretch | 358 | 18 | |||
Control A1 | Static | 1554 | 16 | ||
(72-h) | Stretch | 1080 | 13 | ||
Patient A1 | Static | 292 | 12 | ||
Stretch | 519 | 18 | |||
Patient A1 | Static | 1368 | 13 | ||
(72-h) | Stretch | 1223 | 15 |